XML 46 R28.htm IDEA: XBRL DOCUMENT v3.25.0.1

Segment Reporting (Tables)

12 Months Ended

Jan. 03, 2025

Segment Reporting [Abstract]

Scheduled of Segment Profit, Including Significant Segment Expenses

Summary of the segment net income, including significant segment expenses were as follows (in thousands):

			Year Ended December 31,
			2024						2023						2022
Revenues			$	2,168,701					$	1,830,208					$	1,611,062
Less:
Cost of goods sold			76,216						72,547						57,909
Drug discovery			94,842						215,085						249,713
Development			665,847						669,240						521,622
Selling, general, and administrative			428,962						470,680						397,632
Other segment items(1)			298,350						231,678						182,899
Interest income			(77,156)						(86,543)						(33,065)
Provision for income taxes			160,373						49,756						52,070
Segment and consolidated net income			$	521,267					$	207,765					$	182,282

_________________

(1) Other segment items include stock-based compensation expenses, restructuring expenses, impairment of long-lived assets, other research and development expenses including the allocation of general corporate costs to research and development services and development cost reimbursements in connection with certain of our collaboration arrangements, and other income (expenses), net.

X

- Definition

Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-31

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration